EAGLE PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to Q1 2023.
  • Eagle Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $12.6M.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.21M, a 78.1% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$28.4M, a 25% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$37.9M, a 56.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

EAGLE PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $12.6M +$24M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 -$11.4M -$8.34M -276% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$3.02M -$110M -103% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $107M +$110M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 -$2.66M +$21.2M +88.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$23.9M -$11.9M -99.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$12M -$12M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $0 -$55.3M -100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 $55.3M +$8.26M +17.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $34K +$532K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q1 2014 $47M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$498K Oct 1, 2013 Dec 31, 2013 10-QT 2015-02-17

EAGLE PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$6.21M +$22.2M +78.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 -$28.4M +$9.48M +25% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$37.9M -$13.6M -56.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$24.2M +$63.9M +72.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 -$88.1M -$96.2M -1187% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $8.1M +$41.8M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$33.7M -$89.5M -160% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $55.8M +$9.66M +20.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $46.2M +$36.3M +371% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 $9.81M +$261K +2.73% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 $9.55M Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.